Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...

Explore last week's key healthcare market trends, top gainers & losers, major deals, Trump's tariff plans, FDA approvals, and significant legal updates.

BioNTech has announced the acquisition of fellow German biotech CureVac in an all-stock transaction valued at approximately ...

WIPR ’s newly released UK Patents Rankings 2025 details the best of the UK market for patent work—from the firm that will ...

This special feature contains summaries of “important opinions” published in Virginia Lawyers Weekly during the first half of ...

Even today, in the throes of a norm-busting trade war with China, there is talk of some kind of leader-to-leader grand bargain between U.S. President Donald Trump and his Chinese counterpart, Xi ...

Alex Panetta, a Washington correspondent for CBC News, was in the New York courtroom on Thursday when the jury read out the verdict convicting former U.S. president Donald Trump of 34 charges. Here's ...

Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...

Moderna is suing Pfizer and BioNTech, accusing the companies of infringing on Moderna’s patents when they developed their own COVID-19 vaccine.